Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,835Open textbooks209Open-access articles1,406Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology182Genetics and Genomics170Neuroscience185Cardiovascular Medicine180Immunology142Pharmacology173Molecular Biology161Infectious Diseases150Rare and Inherited Diseases181Clinical Research173Anatomy and Physiology613Drugs and Chemicals621Psychiatry and Psychology185Public Health and Nutrition178Diagnostics and Medical Technology125Respiratory Medicine113Digestive System and Liver91Metabolism and Endocrine Disease177Bones, Joints, Muscles and Skin213Kidney, Urology and Women's Health173Eye, Ear, Nose and Throat55
Plans & pricingCompare EvidenceHelix workspace plans
Library›Open textbooks›Thulium laser transurethral vaporesection versus transurethral resection of the prostate for benign prostatic obstruction: the UNBLOCS RCT›References

Continue where you left off ()

Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Thulium laser transurethral vaporesection versus transurethral resection of the prostate for benign prostatic obstruction: the UNBLOCS RCT · References

References

CC BY 4.0 · NIHR Journals Library · approximately 7 min read

  1. Worthington J, Taylor H, Abrams P, Brookes ST, Cotterill N, Noble SM, et al. A randomised controlled trial to determine the clinical and cost effectiveness of thulium laser transurethral vaporesection of the prostate (ThuVARP) versus transurethral resection of the prostate (TURP) in the National Health Service (NHS) – the UNBLOCS trial: a study protocol for a randomised controlled trial. Trials 2017;18:179. 10.1186/s13063-017-1916-528412960
  2. Hashim H, Worthington J, Abrams P, Young G, Taylor H, Noble SM, et al. Thulium laser transurethral vaporesection of the prostate versus transurethral resection of the prostate for men with lower urinary tract symptoms or urinary retention (UNBLOCS): a randomised controlled trial. Lancet 2020;396:50–61. 10.1016/S0140-6736(20)30537-732622397
  3. Hunter DJ, McKee M, Black NA, Sanderson CF. Health status and quality of life of British men with lower urinary tract symptoms: results from the SF-36. Urology 1995;45:962–71. 10.1016/S0090-4295(99)80116-27539561
  4. McNicholas TA. Management of symptomatic BPH in the UK: who is treated and how? Eur Urol 1999;36(Suppl. 3):33–9. 10.1159/00005234710559629
  5. Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP) – incidence, management, and prevention. Eur Urol 2006;50:969–79. 10.1016/j.eururo.2005.12.04216469429
  6. NHS Digital. NHS Classifications OPCS-4. Leeds: NHS Digital. URL: https://isd.digital.nhs.uk/trud3/user/guest/group/0/pack/10 (accessed 18 September 2019).
  7. Zhang X, Shen P, He Q, Yin X, Chen Z, Gui H, et al. Different lasers in the treatment of benign prostatic hyperplasia: a network meta-analysis. Sci Rep 2016;6:23503. 10.1038/srep2350327009501
  8. National Institute for Health and Care Excellence (NICE). Lower Urinary Tract Symptoms in Men: Management. Clinical guideline [ CG97 ]. London: NICE; 2010.
  9. National Institute for Health and Care Excellence (NICE). GreenLight XPS for Treating Benign Prostatic Hyperplasia. Medical technologies guidance [ MTG29 ]. London: NICE; 2016.
  10. Gilling PJ, Kennett K, Das AK, Thompson D, Fraundorfer MR. Holmium laser enucleation of the prostate (HoLEP) combined with transurethral tissue morcellation: an update on the early clinical experience. J Endourol 1998;12:457–9. 10.1089/end.1998.12.4579847070
  11. National Institute for Health and Care Excellence (NICE). Holmium Laster Prostatectomy. Interventional procedures guidance [ IPG17 ]. London: NICE; 2003. URL: www.nice.org.uk/Guidance/IPG17 (accessed 19 September 2019).
  12. Fried NM, Murray KE. High-power thulium fiber laser ablation of urinary tissues at 1.94 microm. J Endourol 2005;19:25–31. 10.1089/end.2005.19.2515735378
  13. Xia SJ, Zhuo J, Sun XW, Han BM, Shao Y, Zhang YN. Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 2008;53:382–89. 10.1016/j.eururo.2007.05.01917566639
  14. Fu WJ, Zhang X, Yang Y, Hong BF, Gao JP, Cai W, et al. Comparison of 2-microm continuous wave laser vaporesection of the prostate and transurethral resection of the prostate: a prospective nonrandomized trial with 1-year follow-up. Urology 2010;75:194–9. 10.1016/j.urology.2009.07.126619819535
  15. Herrmann TR, Liatsikos EN, Nagele U, Traxer O, Merseburger AS. EAU Guidelines Panel on Lasers, Technologies. EAU guidelines on laser technologies. Eur Urol 2012;61:783–95. 10.1016/j.eururo.2012.01.01022285403
  16. Cui D, Sun F, Zhuo J, Sun X, Han B, Zhao F, et al. A randomized trial comparing thulium laser resection to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia: four-year follow-up results. World J Urol 2014;32:683–9. 10.1007/s00345-013-1103-623913094
  17. Zhang F, Shao Q, Herrmann TR, Tian Y, Zhang Y. Thulium laser versus holmium laser transurethral enucleation of the prostate: 18-month follow-up data of a single center. Urology 2012;79:869–74. 10.1016/j.urology.2011.12.01822342411
  18. Young GMC, Worthington J, Cook J, Hashim H. Statistical Analysis Plan for the UNBLOCS Trial: Version 1.0 (22.11.17). URL: https://research-information.bristol.ac.uk/files/140090744/UNBLOCS_Statistical_Analysis_Plan_v1.0_22.11.17_FINAL.pdf (accessed 19 September 2019).
  19. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205–13. 10.1097/01.sla.0000133083.54934.ae15273542
  20. Barry MJ, Cantor A, Roehrborn CG, CAMUS Study Group. Relationships among participant international prostate symptom score, benign prostatic hyperplasia impact index changes and global ratings of change in a trial of phytotherapy in men with lower urinary tract symptoms. J Urol 2013;189:987–92. 10.1016/j.juro.2012.08.25723017510
  21. Hammadeh MY, Madaan S, Hines J, Philp T. 5-year outcome of a prospective randomized trial to compare transurethral electrovaporization of the prostate and standard transurethral resection. Urology 2003;61:1166–71. 10.1016/S0090-4295(03)00109-212809891
  22. Montorsi F, Naspro R, Salonia A, Suardi N, Briganti A, Zanoni M, et al. Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center, prospective, randomized trial in patients with obstructive benign prostatic hyperplasia. J Urol 2004;172:1926–9. 10.1097/01.ju.0000140501.68841.a115540757
  23. Schumi J, Wittes JT. Through the looking glass: understanding non-inferiority. Trials 2011;12:106. 10.1186/1745-6215-12-10621539749
  24. Schoenfeld D. Chi-squared goodness of fit tests for the proportional hazards regression model. Biometrika 1980;67:145–53. 10.1093/biomet/67.1.145
  25. Donovan JL, Hamdy FC, Lane JA, Mason M, Metcalfe C, Walsh E, et al. Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med 2016;375:1425–37. 10.1056/NEJMoa160622127626365
  26. International Prostate Symptom Score (IPSS). URL: www.urospec.com/uro/Forms/ipss.pdf (accessed 18 March 2018).
  27. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med 2011;30:377–99. 10.1002/sim.406721225900
  28. Piaggio G, Elbourne DR, Pocock SJ, Evans SJ, Altman DG, CONSORT Group. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA 2012;308:2594–604. 10.1001/jama.2012.8780223268518
  29. Noble SM, Ahern AM, Worthington J, Hashim H, Taylor H, Young GJ, et al. The cost-effectiveness of transurethral resection of the prostate vs thulium laser transurethral vaporesection of the prostate in the UNBLOCS randomised controlled trial for benign prostatic obstruction. BJUI Int 2020. 10.1111/bju.15138
  30. van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health 2012;15:708–15. 10.1016/j.jval.2012.02.00822867780
  31. NHS Improvement. NHS Reference Costs 2016/17. URL: https://improvement.nhs.uk/resources/reference-costs/ (accessed 18 March 2018).
  32. Curtis L, Burns A. Unit Costs of Health and Social Care 2017. Canterbury: Personal Social Services Research Unit, University of Kent; 2017.
  33. Curtis L. Unit Costs of Health and Social Care 2013. Canterbury: Personal Social Services Research Unit, University of Kent; 2013.
  34. Curtis L, Burns A. Unit Costs of Health and Social Care 2015. Canterbury: Personal Social Services Research Unit, University of Kent; 2015.
  35. Pope C, Turnbull J, Jones J, Prichard J, Rowsell A, Halford S. Has the NHS 111 urgent care telephone service been a success? Case study and secondary data analysis in England. BMJ Open 2017;7:e014815. 10.1136/bmjopen-2016-014815
  36. HM Revenue and Customs. Travel – Mileage and Fuel Rates and Allowances. URL: www.gov.uk/government/publications/rates-and-allowances-travel-mileage-and-fuel-allowances/travel-mileage-and-fuel-rates-and-allowances (accessed 12 September 2018).
  37. NHS Business Services Authority. NHS Drug Tariff. URL: www.nhsbsa.nhs.uk/pharmacies-gp-practices-and-appliance-contractors/drug-tariff (accessed 13 September 2018).
  38. World Health Organization. International Classification of Diseases, Tenth Revision. Geneva: World Health Organization; 2016. URL: www.who.int/classifications/icd/icdonlineversions/en/ (accessed 18 September 2019).
  39. Drummond MF. Methods for the Economic Evaluation of Health Care Programmes. 3rd edn. Oxford: Oxford University Press; 2005.
  40. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997;35:1095–108. 10.1097/00005650-199711000-000029366889
  41. Joint Formulary Committee. British National Formulary (online). London: BMJ Group and Pharmaceutical Press. URL: https://bnf.nice.org.uk/ (accessed 13 September 2018).
  42. Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ 2005;14:487–96. 10.1002/hec.94415497198
  43. Marques E, Johnson EC, Gooberman-Hill R, Blom AW, Noble S. Using resource use logs to reduce the amount of missing data in economic evaluations alongside trials. Value Health 2013;16:195–201. 10.1016/j.jval.2012.09.00823337231
  44. Al-Busaidi ZQ. Qualitative research and its uses in health care. Sultan Qaboos Univ Med J 2008;8:11–19.21654952
  45. Lewin S, Glenton C, Oxman AD. Use of qualitative methods alongside randomised controlled trials of complex healthcare interventions: methodological study. BMJ 2009;339:b3496. 10.1136/bmj.b349619744976
  46. Hudak PL, McKeever PD, Wright JG. Understanding the meaning of satisfaction with treatment outcome. Med Care 2004;42:718–25. 10.1097/01.mlr.0000132398.11342.a815258473
  47. Braun V, Clark V. Using thematic analysis in psychology. Qual Res Psychol 2006;3:77–101. 10.1191/1478088706qp063oa
  48. Fusch PI, Ness LR. Are we there yet? Data saturation in qualitative research. Qual Rep 2015;20:1408.
  49. Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006;50:1306–14. 10.1016/j.eururo.2006.09.01917049716
  50. Cobussen-Boekhorst H, Hermeling E, Heesakkers J, van Gaal B. Patients’ experience with intermittent catheterisation in everyday life. J Clin Nurs 2016;25:1253–61. 10.1111/jocn.1314626991436
  51. Gadow S. Body and self: a dialectic. J Med Philos 1980;5:172–85. 10.1093/jmp/5.3.1726162903
  52. Taylor AW, Wilson DH, Wakefield M. Differences in health estimates using telephone and door-to-door survey methods – a hypothetical exercise. Aust N Z J Public Health 1998;22:223–6. 10.1111/j.1467-842X.1998.tb01177.x9744181
  53. Burgio KL, Brubaker L, Richter HE, Wai CY, Litman HJ, France DB, et al. Patient satisfaction with stress incontinence surgery. Neurourol Urodyn 2010;29:1403–9. 10.1002/nau.2087720976815
  54. Hamilton DF, Lane JV, Gaston P, Patton JT, Macdonald D, Simpson AH, Howie CR. What determines patient satisfaction with surgery? A prospective cohort study of 4709 patients following total joint replacement. BMJ Open 2013;3:e002525. 10.1136/bmjopen-2012-002525
  55. NICE. NICE Guideline [NG131]. London: NICE; 2019.
  56. NHS Digital. Hospital Admitted Patient Care Activity, 2013–14. URL: https://webarchive.nationalarchives.gov.uk/20190305041047/https://digital.nhs.uk/data-and-information/publications/statistical/hospital-admitted-patient-care-activity/hospital-episode-statistics-admitted-patient-care-england-2013-14 (accessed 18 September 2019).
  57. NHS Digital. Hospital Admitted Patient Care Activity, 2016–17. URL: https://digital.nhs.uk/data-and-information/publications/statistical/hospital-admitted-patient-care-activity/2016-17 (accessed 18 September 2019).
  58. Loeb S, Han M, Roehl KA, Antenor JA, Catalona WJ. Accuracy of prostate weight estimation by digital rectal examination versus transrectal ultrasonography. J Urol 2005;173:63–5. 10.1097/01.ju.0000145883.01068.5f15592029
  59. Deng Z, Sun M, Zhu Y, Zhuo J, Zhao F, Xia S, et al. Thulium laser VapoResection of the prostate versus traditional transurethral resection of the prostate or transurethral plasmakinetic resection of prostate for benign prostatic obstruction: a systematic review and meta-analysis. World J Urol 2018;36:1355–64. 10.1007/s00345-018-2287-629651642
  60. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377–81. 10.1016/j.jbi.2008.08.01018929686
← Discussion and conclusionsAcknowledgements →

Attribution. Jo Worthington; J Athene Lane; Hilary Taylor; Grace Young; Sian M Noble; Paul Abrams et al. (2020). Thulium laser transurethral vaporesection versus transurethral resection of the prostate for benign prostatic obstruction: the UNBLOCS RCT. NIHR Journals Library. Copyright © Queen’s Printer and Controller of HMSO 2020. This work was produced by Worthington et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK. Licensed under CC BY 4.0. NCBI Bookshelf NBK561601. CC BY 4.0. Original source ↗. Text reproduced from the Bookshelf XML without changing wording; figures, images and supplements are not reproduced.

In this chapter Contents

  • References

Source

OpenStax source file ↗

Source record ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Rights and removal requests · Legal · Support